Grove Bank & Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2M | Buy |
15,556
+748
| +5% | +$87.6K | 0.2% | 78 |
|
|
2026
Q1 | $1.78M | Sell |
14,808
-55
| -0.4% | -$6.35K | 0.2% | 79 |
|
|
2025
Q4 | $1.56M | Sell |
14,863
-136
| -0.9% | -$12.8K | 0.18% | 81 |
|
|
2025
Q3 | $1.26M | Sell |
14,999
-596
| -4% | -$49.1K | 0.15% | 95 |
|
|
2025
Q2 | $1.23M | Sell |
15,595
-1,502
| -9% | -$119K | 0.15% | 94 |
|
|
2025
Q1 | $1.53M | Buy |
17,097
+1,809
| +12% | +$169K | 0.21% | 83 |
|
|
2024
Q4 | $1.52M | Buy |
15,288
+812
| +6% | +$83.7K | 0.21% | 80 |
|
|
2024
Q3 | $1.64M | Buy |
14,476
+178
| +1% | +$21.1K | 0.24% | 76 |
|
|
2024
Q2 | $1.77M | Buy |
14,298
+353
| +3% | +$45.5K | 0.28% | 66 |
|
|
2024
Q1 | $1.84M | Sell |
13,945
-47
| -0.3% | -$5.79K | 0.31% | 62 |
|
|
2023
Q4 | $1.53M | Sell |
13,992
-826
| -6% | -$85.7K | 0.28% | 67 |
|
|
2023
Q3 | $1.53M | Sell |
14,818
-378
| -2% | -$40.7K | 0.31% | 64 |
|
|
2023
Q2 | $1.75M | Buy |
15,196
+4
| +0% | +$454 | 0.35% | 57 |
|
|
2023
Q1 | $1.62M | Sell |
15,192
-3,413
| -18% | -$368K | 0.34% | 60 |
|
|
2022
Q4 | $2.06M | Sell |
18,605
-11,715
| -39% | -$1.2M | 0.46% | 46 |
|
|
2022
Q3 | $2.61M | Buy |
30,320
+79
| +0.3% | +$7.05K | 0.65% | 34 |
|
|
2022
Q2 | $2.76M | Sell |
30,241
-1,394
| -4% | -$124K | 0.66% | 36 |
|
|
2022
Q1 | $2.6M | Sell |
31,635
-121
| -0.4% | -$9.54K | 0.51% | 45 |
|
|
2021
Q4 | $2.43M | Buy |
31,756
+996
| +3% | +$79.3K | 0.46% | 51 |
|
|
2021
Q3 | $2.31M | Buy |
30,760
+1,265
| +4% | +$96.2K | 0.49% | 47 |
|
|
2021
Q2 | $2.29M | Sell |
29,495
-195
| -0.7% | -$14.5K | 0.5% | 47 |
|
|
2021
Q1 | $2.18M | Buy |
29,690
+264
| +0.9% | +$19.5K | 0.51% | 44 |
|
|
2020
Q4 | $2.3M | Buy |
29,426
+2,286
| +8% | +$175K | 0.6% | 38 |
|
|
2020
Q3 | $2.15M | Sell |
27,140
-632
| -2% | -$49.5K | 0.66% | 36 |
|
|
2020
Q2 | $2.05M | Buy |
27,772
+2,324
| +9% | +$175K | 0.67% | 34 |
|
|
2020
Q1 | $1.87M | Sell |
25,448
-805
| -3% | -$63.3K | 0.74% | 34 |
|
|
2019
Q4 | $2.28M | Sell |
26,253
-1,187
| -4% | -$97.5K | 0.68% | 32 |
|
|
2019
Q3 | $2.2M | Buy |
27,440
+1,828
| +7% | +$147K | 0.71% | 30 |
|
|
2019
Q2 | $2.05M | Sell |
25,612
-1,905
| -7% | -$146K | 0.75% | 28 |
|
|
2019
Q1 | $2.18M | Sell |
27,517
-626
| -2% | -$46.8K | 0.84% | 27 |
|
|
2018
Q4 | $2.05M | Sell |
28,143
-2,863
| -9% | -$202K | 0.96% | 25 |
|
|
2018
Q3 | $2.1M | Sell |
31,006
-2,832
| -8% | -$180K | 0.86% | 27 |
|
|
2018
Q2 | $1.96M | Sell |
33,838
-1,800
| -5% | -$102K | 0.83% | 30 |
|
|
2018
Q1 | $1.85M | Buy |
35,638
+110
| +0.3% | +$5.94K | 0.82% | 30 |
|
|
2017
Q4 | $1.91M | Buy |
35,528
+530
| +2% | +$29.4K | 0.83% | 26 |
|
|
2017
Q3 | $2.14M | Buy |
34,998
+503
| +1% | +$30.5K | 1.04% | 21 |
|
|
2017
Q2 | $2.11M | Buy |
34,495
+4,905
| +17% | +$299K | 1.35% | 16 |
|
|
2017
Q1 | $1.79M | Sell |
29,590
-4,393
| -13% | -$267K | 1.47% | 16 |
|
|
2016
Q4 | $1.91M | Buy |
33,983
+3,805
| +13% | +$223K | 1.46% | 15 |
|
|
2016
Q3 | $1.8M | Buy |
30,178
+1,215
| +4% | +$71K | 1.53% | 16 |
|
|
2016
Q2 | $1.59M | Buy |
28,963
+898
| +3% | +$47.8K | 1.43% | 17 |
|
|
2016
Q1 | $1.42M | Buy |
28,065
+515
| +2% | +$25.2K | 1.29% | 23 |
|
|
2015
Q4 | $1.39M | Buy |
+27,550
| New | +$1.39M | 1.25% | 19 |
|
Other funds holding MRK
ECSS
Grove Bank & Trust's MRK Position: Q2 2026 in Review
Grove Bank & Trust increased its Merck (MRK) stake by 5.1% in Q2 2026, buying an estimated $87.6K and bringing the position to 15,556 shares worth $2M. The position accounts for 0.2% of the portfolio, ranked #78.
Grove Bank & Trust first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $2.76M in Q2 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Grove Bank & Trust held 15,556 shares of Merck worth $2M as of Q2 2026.
- Grove Bank & Trust bought 748 Merck shares in Q2 2026, an estimated $87.6K.
- Merck made up 0.2% of Grove Bank & Trust's portfolio in Q2 2026, its #78 holding.
- Grove Bank & Trust first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
- Grove Bank & Trust's Merck position peaked at $2.76M in Q2 2022.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.